COVID-19 vaccines worth Rs 338 crores exported from India so far: Piyush Goyal

India’s exports of the COVID-19 vaccine stood at around Rs 338 crores till February 8, Commerce and Industry Minister Piyush Goyal said in the Rajya Sabha.

The exports include grant of the vaccine doses to friendly countries and commercial shipments.

Replying to supplementary questions in the House, Goyal said exports of the vaccine started in January.

India is taking care of the domestic vaccine requirement first and based on that “giving vaccines to friendly countries,” he said.

“Total export is about Rs 338 crore worth of COVID vaccine,” the minister said.

Giving details, Goyal said export of Covishield vaccine manufactured by the Serum Insitute of India, Pune as Government of India grant stood at 62.7 lakh doses with FoB (free on board) value of about Rs 125.4 crore.

Paid exports of 1.05 crore doses were valued at about Rs 213.32 crore.

Goyal said the government has granted permission to the Serum Institute and Bharat Biotech, Hyderabad to manufacture COVID-19 vaccines.